Goodpath Secures $18M to Expand AI-Driven Healthcare Platform

Goodpath has raised $18 million in Series A funding, led by MassMutual Ventures, announced in a press release. The funding will be used to accelerate the expansion of its AI-driven, clinically-validated care model, which integrates treatment for chronic conditions such as weight management, musculoskeletal pain, sleep, digestive health, mental health, diabetes, and cancer survivorship.

Co-founded by CEO Bill Gianoukos and Dr. Akl Fahed, Goodpath aims to address the fragmented nature of chronic condition care in the U.S. by providing a seamless, integrative care experience. The platform leverages a learning care model powered by a growing dataset of over 4.5 million real-world data points, enabling it to improve recommendations and tailor care pathways to individual needs.

The new funding will also support the development of outcome prediction models, AI-led personalization tools, and expanded product capabilities, including prescribing and complex care navigation. Goodpath's approach aims to deliver cost savings for employers and improved health outcomes for their workforces.